GLP-1 Injection Weight Loss Program (Oral GLP-1 treatment options may be considered based on eligibility) Semaglutide and Liraglutide are GLP-1 medications administered by subcutaneous injection to support long-term weight loss
J., Perz-Martinez, P., Lpez-Miranda, J., & Prez-Jimnez, F
If not addressed, stomach paralysis may lead to malnutrition, dehydration, and blood sugar complications
Use of glucagon-like peptide-1 receptor agonists for type 2 diabetes mellitus and outcomes of inflammatory bowel disease
This helps them expand their product lines, especially in obesity and type 2 diabetes
For weight management, NICE technology appraisals specify eligibility criteria including minimum BMI thresholds and require initiation within specialist weight management services